Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × avatrombopag × Clear all

NCT06001567 2023-09-14

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Phase 2 Unknown

Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia